H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
H5N1 Strain Shows Limited Airborne Transmission in Ferrets

H5N1 Strain Shows Limited Airborne Transmission in Ferrets

New System to Quickly Detect Airborne Viruses Using High-Speed Train Technology

New System to Quickly Detect Airborne Viruses Using High-Speed Train Technology

Effective and faster methodology detects RNA viruses based on the triplex-forming probe technology

Effective and faster methodology detects RNA viruses based on the triplex-forming probe technology

New biosensor could achieve the speed, efficiency required for COVID-19 testing in future

New biosensor could achieve the speed, efficiency required for COVID-19 testing in future

Pairing microscopy with AI to develop a rapid, accurate COVID-19 test

Pairing microscopy with AI to develop a rapid, accurate COVID-19 test

Three plausible solutions mitigates zoonotic risk associated with intensive animal agriculture

Three plausible solutions mitigates zoonotic risk associated with intensive animal agriculture

Study shows how human viruses are better adapted to infect certain tissues

Study shows how human viruses are better adapted to infect certain tissues

TGen identifies genetic target that could help explain the variation in COVID-19 effects

TGen identifies genetic target that could help explain the variation in COVID-19 effects

Specific immune mechanism in COVID-19 patients triggers inflammatory process

Specific immune mechanism in COVID-19 patients triggers inflammatory process

Researchers identify new potential therapeutic targets for SARS-CoV-2 infection

Researchers identify new potential therapeutic targets for SARS-CoV-2 infection

Research on broadly neutralizing antibodies may lead to universal flu vaccine

Research on broadly neutralizing antibodies may lead to universal flu vaccine

Study shows how a fat cell's immune response exacerbates obesity

Study shows how a fat cell's immune response exacerbates obesity

Single-cell cloning can lead to new therapies for COPD

Single-cell cloning can lead to new therapies for COPD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.